0001179110-21-008584.txt : 20210903 0001179110-21-008584.hdr.sgml : 20210903 20210903160607 ACCESSION NUMBER: 0001179110-21-008584 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210902 FILED AS OF DATE: 20210903 DATE AS OF CHANGE: 20210903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boulding Mark Elliott CENTRAL INDEX KEY: 0001578852 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 211236502 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 edgar.xml FORM 4 - X0306 4 2021-09-02 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001578852 Boulding Mark Elliott C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 Exec. VP and CLO Common Stock 2021-09-02 4 M 0 3363 18.01 A 51737 D Common Stock 2021-09-02 4 S 0 3363 45.012 D 48374 D Stock Option (Right to Buy) 18.01 2021-09-02 4 M 0 3363 18.01 D 2028-01-02 Common Stock 3363 15653 D Stock Option (Right To Buy) 218.4 2022-01-10 Common Stock 191.0 191 D Stock Option (Right To Buy) 51.0 2025-01-01 Common Stock 85600.0 85600 D Stock Option (Right To Buy) 30.86 2026-01-03 Common Stock 70000.0 70000 D Stock Option (Right to Buy) 11.23 2027-01-02 Common Stock 4563 4563 D Stock Option (Right To Buy) 33.02 2029-01-21 Common Stock 72500.0 72500 D Stock Option (Right To Buy) 33.02 2029-01-21 Common Stock 17500.0 17500 D Stock Option (Right To Buy) 51.16 2030-01-28 Common Stock 59500.0 59500 D Stock Option (Right to Buy) 66.49 2031-01-05 Common Stock 59500 59500 D This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on March 10, 2021. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Currently exercisable. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021. This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022. /s/ Avraham S. Adler, attorney-in-fact 2021-09-03